FREE CONSULTATION - CALL NOW!

212-LAWYERS or (212) 344-1000

Alzheimer’s risks may increase with prostate cancer treatment

In dealing with cancer, a New York health care practitioner may find that some treatments involve certain risk factors. This means that it is important to work with a patient to find the right balance between treatment and risk. In the case of treating prostate cancer, for example, a primary approach to addressing the disease involves androgen deprivation therapy due to the role that testosterone can have in causing tumors to grow. A study, however, indicates that there may be a greater potential for a patient going through ADT to later be diagnosed with Alzheimer’s.

Read More Β»

A Trained Eye: Take Safety Seriously

Part of the training of an injury lawyer involves being able to look at a worksite and identify safety issues or potential liability. But sometimes, these skills are sadly misplaced. They should not just be part of the injury attorney’s toolkit — they should also be part of what a competent manager or supervisor or other business leader brings to the job. So often, when work injury cases go to trial, it’s because there are any number of skilled people in the justice system who can see clear evidence of negligence or lack of attention to safety, but in the days and weeks and months before an accident, there was no one onsite who could understand that poor safety precautions were a liability for the company.

A Culture of β€œDon’t Worry About It”

Read More Β»

Screening for celiac disease

New York residents genetically predisposed to celiac disease may develop the autoimmune condition either as a child or as an adult. The disease is usually confined to the small intestine, but symptoms are not always apparent and regular screening for at-risk individuals is highly recommended. Screening for celiac disease involves both antibody and genetic testing.

Read More Β»

Many medical tests are not reviewed by the FDA

New York patients may be dismayed to find out that many of the medical tests performed each year in the United States are not reviewed and approved by the Food and Drug Administration. A 1988 law gives the FDA authority to review only tests that are sold to multiple labs, which allows thousands of tests to be performed each year that have not been required to undergo any kind of official scrutiny. The FDA also points out that only about 1 percent of the nation’s approximately 180,000 medical labs have ever been inspected.

Read More Β»
NYC Personal Injury lawyer - RMFW Law Logo Inverted

Get a Free Consultation

No Win No Fee